跳至主要内容
临床试验/NCT02381106
NCT02381106暂停不适用

The ADRB3 Adrenergic Receptor - a Possible New Target for Controlling Pre-eclampsia and Hypertension in Pregnancy and Uterine Contractions in Non-pregnant and Pregnant Myometrium

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
入组人数
80
试验地点
1
主要终点
characterization of the levels of the ADRB3 receptor in human pregnant myometrium

研究概览

简要总结

The primary overall objective of this study is to characterize the levels of and compare levels of the ADRB3 receptor in human non-pregnant myometrium, pregnant myometrium at different time points in pregnancy, in normal and dysfunctional labor and also to measure levels and expression of these receptors in placental arteries at different maturation statuses of placenta and in pre-eclampsia/hypertension

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women undergoing cesarian section

排除标准

  • Interkurrent diseases

结局指标

主要结局

characterization of the levels of the ADRB3 receptor in human pregnant myometrium

时间窗: 1 month

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Helena Kopp Kallner

MD, PhD

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验

The ADRB3 Receptor in Pregnancy | 临床试验